Clinical trial
Study of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active…
NCT00049751 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00049751 |
|---|---|
| Title | Study of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active Rheumatoid Arthritis |
| Official title | A Multicenter Study of the Safety of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active Rheumatoid Arthritis |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | Adalimumab |
| Enrollment | 3,000 |
| Start date | Sep 1, 2002 |
| First posted | Nov 14, 2002 |
| Last update posted | Aug 15, 2006 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: